Article
Eyetech Pharmaceuticals and Archemix Corp. agreed to collaborate on the research and development of aptamers to develop for use in the treatment of ophthalmic diseases.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.